Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abcam
MedTech
Danaher's 2023 sales drop 10% during 'transformational year'
2023 saw Danaher spin out one slate of companies and acquire another, while COVID testing tailwinds turned into headwinds, CEO Rainer Blair said.
Conor Hale
Jan 30, 2024 2:35pm
Abcam ups rabbit mAb presence with acquisition of Calico Biolabs
Jan 31, 2019 7:55am
Abcam ends pursuit of £270M Horizon Discovery buyout
May 9, 2018 8:51am
Horizon Discovery rejects Abcam’s £270M buyout bid
May 3, 2018 6:00am
Abcam, Molecular Devices combine expertise in immunoassays
Feb 7, 2018 9:04am
